|
|
|
|
| Can CDMOs Keep Up With the Next Generation of Medicine? Join us November 11, 2026, at 11 AM ET for Outsourcing the Uncharted: Manufacturing Complex and Emerging Therapies, a free expert panel exploring the challenges of outsourcing complex, personalized, and live-cell products—and how innovators are finding specialized CDMO partners to bring breakthrough therapies to patients. Register today! |
|
|
|
|
|
| Harness High-Quality PBPK Modeling To Enhance Clinical Readiness | Article | By Deanna Mudie, Ph.D. and John DiBella, Lonza | Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Consultants tell Chief Editor Louis Garguilo that too often those who should know better – from executives to project managers – overestimate their ability to manage CMC activities. | |
|
|
September 2026 — CDMO Opportunities And Threats Report | By GlobalData | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
|
| Open-Label Study Assessing Relative And Absolute Bioavailability | White Paper | By Andy Sykes, Helena Engman, Nigel Taylor, et al., Quotient Sciences | Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions. |
|
|
| Patient-Centric Formulations In Pediatric Adherence | Article | By Srinivasan Shanmugam, Ph.D., Adare Pharma Solutions | Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers for children. |
|
|
| Segments: Next-Generation Tablet Press Technology | Guest Article/Blog | By Todd Martin, Natoli Engineering Company, Inc. | Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology. |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
